Cite
A multicenter real-life U.K. study of use of immunotherapeutic agents in metastatic urothelial cancer
MLA
Prantik Das, et al. “A Multicenter Real-Life U.K. Study of Use of Immunotherapeutic Agents in Metastatic Urothelial Cancer.” Journal of Clinical Oncology, vol. 40, Feb. 2022, p. 504. EBSCOhost, https://doi.org/10.1200/jco.2022.40.6_suppl.504.
APA
Prantik Das, Anand Sharma, Ruchir Bhandari, JunHao Lim, Aruni Ghose, Jessica Davies, Ajith Nair, Nikhil Vasdev, Maja Moldawa, Ahmad Karimi, Colin Ward, Alison Richardson, Sadmeet Singh, Amjad Peracha, & Shaista Ahmed. (2022). A multicenter real-life U.K. study of use of immunotherapeutic agents in metastatic urothelial cancer. Journal of Clinical Oncology, 40, 504. https://doi.org/10.1200/jco.2022.40.6_suppl.504
Chicago
Prantik Das, Anand Sharma, Ruchir Bhandari, JunHao Lim, Aruni Ghose, Jessica Davies, Ajith Nair, et al. 2022. “A Multicenter Real-Life U.K. Study of Use of Immunotherapeutic Agents in Metastatic Urothelial Cancer.” Journal of Clinical Oncology 40 (February): 504. doi:10.1200/jco.2022.40.6_suppl.504.